Videos

Roving Reporter Asks: What’s Your Tech Wishlist in CGT?

IBTV interviews 3 experts from the 2025 Cell & Gene Therapy Summit in London about advances in technology.

Roving Reporter Asks: What Are the Biggest Hurdles in Cell and Gene Therapy Development?

IBTV interviews show that funding and investment panic are dominating industry concerns.

From the Apollo Era to the World's First Cell Therapy

Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.

Preparing for CPHI 2025 in Frankfurt

Our interview with Tara Dougal offers a snapshot of what to expect at the event.

The Medicine Maker Presents Sharing is Caring: The Secrets of CGT

From standardizing CAR-T manufacturing to blockchain-backed data sharing, this roundtable tackles what it takes to scale life-saving advanced therapies.

The Priorities for Cell and Gene in 2025 and 2026

Thirteen experts give their views – with improving patient access to these therapies being a key theme.

What’s Your Tech Wishlist for Cell and Gene Therapy?

Eleven experts tell us what’s at the top of their technology or equipment wishlist in the cell and gene therapy sector.

CGT Manufacturing Capacity: Battle of the CDMOs

Capacity has been built for cell and gene therapy manufacturing, but will demand keep pace? CDMOs may face a battle for survival.

Video Interview: Claus Zieler of Astellas and EFPIA

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe

Just – Evotec Biologics Expands in Europe